Address :132-A BUSINESS CENTER DR CORONA, CA, 92880-1724 UNITED STATES | |||
Status : A | Type : A | Woman Owned : N | Business Type : N |
Business Size : A | Primary Business : J | CAO Code : S0513A | ADP Code : HQ0339 |
Part No | Item Name | Manufacturer | NSN | QTY | RFQ |
---|---|---|---|---|---|
NDC00536-0510-85 | triprolidine and pseudoephedrine hydrochloride syr | watson labs inc | 6505-00-753-9612 | Avl | RFQ |
NDC00536-3231-01 | acetaminophen table | watson labs inc | 6505-01-075-3175 | Avl | RFQ |
NDC00536-4074-10 | niacin extended rel | watson labs inc | 6505-01-283-0164 | Avl | RFQ |
NDC00536-4075-01 | niacin extended rel | watson labs inc | 6505-01-169-7487 | Avl | RFQ |
NDC00591-0343-01 | verapamil tablets u | watson labs inc | 6505-01-135-4251 | Avl | RFQ |
NDC00591-0369-01 | loxapine capsules usp | watson labs inc | 6505-01-270-5970 | Avl | RFQ |
NDC00591-0416-01 | estropipate tablets usp | watson labs inc | 6505-01-214-8733 | Avl | RFQ |
NDC00591-0460-05 | glipizide tablets u | watson labs inc | 6505-01-244-9942 | Avl | RFQ |
NDC00591-0491-01 | mexiletine hydrochl | watson labs inc | 6505-01-256-6367 | Avl | RFQ |
NDC00591-0606-05 | labetalol hydrochlo | watson labs inc | 6505-01-208-5995 | Avl | RFQ |
NDC00591-0782-01 | diethylpropion hydrochloride extended release tabl | watson labs inc | 6505-01-234-9586 | Avl | RFQ |
NDC00591-0786-01 | chlordiazepoxide hydrochloride capsules usp | watson labs inc | 6505-01-169-0283 | Avl | RFQ |
NDC00591-0787-05 | chlordiazepoxide hy | watson labs inc | 6505-00-059-9019 | Avl | RFQ |
NDC00591-0794-01 | dicyclomine hydroch | watson labs inc | 6505-01-145-8827 | Avl | RFQ |
NDC00591-0810-85 | sulfadiazine silver | watson labs inc | 6505-01-280-4733 | Avl | RFQ |
NDC00591-2520-05 | chlorzoxazone table | watson labs inc | 6505-01-315-5359 | Avl | RFQ |
NDC00591-5052-10 | prednisone tablets | watson labs inc | 6505-00-530-6470 | Avl | RFQ |
NDC00591-5059-10 | prednisolone tablets usp | watson labs inc | 6505-01-235-1382 | Avl | RFQ |
NDC00591-5438-01 | quinidine sulfate t | watson labs inc | 6505-00-138-7400 | Avl | RFQ |
NDC00591-5556-01 | propranolol hydroch | watson labs inc | 6505-00-106-7399 | Avl | RFQ |
NDC00591-5658-05 | cyclobenzaprine hyd | watson labs inc | 6505-01-356-3877 | Avl | RFQ |
NDC00591-5715-01 | amoxapine tablets u | watson labs inc | 6505-01-111-3194 | Avl | RFQ |
NDC52544-0242-01 | lorazepam tablets u | watson labs inc | 6505-01-062-8008 | Avl | RFQ |
NDC52544-0265-28 | norethindrone and mestranol tablets usp | watson labs inc | 6505-01-445-9191 | Avl | RFQ |
NDC52544-0301-05 | furosemide tablets | watson labs inc | 6505-00-254-5546 | Avl | RFQ |
NDC52544-0308-05 | propranolol hydrochloride tablets usp | watson labs inc | 6505-01-376-6535 | Avl | RFQ |
NDC52544-0348-01 | triamterene and hyd | watson labs inc | 6505-01-196-5402 | Avl | RFQ |
NDC52544-0349-01 | hydrocodone bitartr | watson labs inc | 6505-01-189-9903 | Avl | RFQ |
NDC52544-0371-10 | loxapine capsules u | watson labs inc | 6505-01-048-3719 | Avl | RFQ |
NDC52544-0372-01 | loxapine capsules usp | watson labs inc | 6505-01-190-6285 | Avl | RFQ |
NDC52544-0395-01 | pentazocine and nal | watson labs inc | 6505-00-180-6030 | Avl | RFQ |
NDC52544-0418-05 | cyclobenzaprine hyd | watson labs inc | 6505-01-356-3877 | Avl | RFQ |
NDC52544-0460-05 | glipizide tablets u | watson labs inc | 6505-01-244-9942 | Avl | RFQ |
NDC52544-0484-01 | diltiazem extended release capsules usp | watson labs inc | 6505-01-355-3601 | Avl | RFQ |
NDC52544-0560-01 | glyburide tablets usp | watson labs inc | 6505-01-430-7234 | Avl | RFQ |
NDC52544-0575-10 | trihexyphenidyl hydrochloride tablets usp | watson labs inc | 6505-01-153-3963 | Avl | RFQ |
NDC52544-0596-01 | clomipramine hydrochloride capsules | watson labs inc | 6505-01-318-7402 | Avl | RFQ |
NDC52544-0606-05 | labetalol hydrochlo | watson labs inc | 6505-01-208-5995 | Avl | RFQ |
NDC52544-0682-05 | alprazolam tablets | watson labs inc | 6505-01-197-3966 | Avl | RFQ |
NDC52544-0697-10 | doxepin hydrochlori | watson labs inc | 6505-00-405-9261 | Avl | RFQ |
NDC52544-0782-01 | diethylpropion hydrochloride extended release tabl | watson labs inc | 6505-01-234-9586 | Avl | RFQ |
NDC52544-0787-05 | chlordiazepoxide hy | watson labs inc | 6505-00-059-9019 | Avl | RFQ |
NDC52544-0801-05 | hydroxyzine pamoate | watson labs inc | 6505-00-765-0824 | Avl | RFQ |
NDC52544-0809-01 | desipramine hydrochloride tablets usp | watson labs inc | 6505-01-341-7466 | Avl | RFQ |
NDC52544-0812-01 | loxapine capsules u | watson labs inc | 6505-01-200-5786 | Avl | RFQ |
NDC52544-0815-34 | loxapine hydrochlor | watson labs inc | 6505-01-026-0101 | Avl | RFQ |
NDC52544-0931-02 | iron dextran injection usp | watson labs inc | 6505-01-362-8314 | Avl | RFQ |
NDC52544-0956-01 | butalbital aspirin | watson labs inc | 6505-01-219-8564 | Avl | RFQ |
NDC55515-0035-15 | flurandrenolide cre | watson labs inc | 6505-00-890-1554 | Avl | RFQ |
NDC55515-0056-04 | cinoxacin capsules usp | watson labs inc | 6505-01-147-5566 | Avl | RFQ |
All Orders are Fulfilled in the U.S.A.
All shipments must comply with U.S.A export laws.
No exceptions.
The only independent distributor
with a NO CHINA SOURCING Pledge
“We Proudly Support Intrepid Fallen Heroes Fund that serves United States Military Personal experiencing the Invisible Wounds of War : Traumatic Brain Injury (TBI) and Post Traumatic Stress (PTS). Please visit website (www.fallenheroesfund.org) and help in their valiant effort”.
Don’t forget That We offer 24/7 Service, Competitive Prices, and Fast Deliveries. We Hope You'll Make Us Your One-Stop Purchasing Solution!
Request for Quote